Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
Shirin Karimi(Princess Margaret Cancer Centre), Gelareh Zadeh(University Health Network)
Cited by 55
Related Papers
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
|Acta Neuropathologica|2023|48
Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities
|Nature Communications|2023|44
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
|bioRxiv (Cold Spring Harbor Laboratory)|2022|8